We are live on ! Find out more
ZOM

Zomedica Corp.
ZOM

Delisted

ZOM was delisted on the 4th of March, 2025.

Back to rankings

32 hedge funds and large institutions have $3.59M invested in Zomedica Corp. in 2020 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 10 increasing their positions, 2 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 2

44% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 9

14% more funds holding

Funds holding: 28 → 32 (+4)

39% less capital invested

Capital invested by funds: $5.94M → $3.59M (-$2.35M)

Holders
32
Holders Change
+4
Holders Change %
+14.29%
% of All Funds
0.64%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
10
Reduced
2
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$387K
2
Millennium Management
Millennium Management
New York
+$260K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$243K
4
WG
Winton Group
United Kingdom
+$98.9K
5
Citadel Advisors
Citadel Advisors
Florida
+$82K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$221K
2
CCFM
Clear Creek Financial Management
Washington
-$95K
3
Barclays
Barclays
United Kingdom
-$84.7K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$19.2K
5
ECM
ETrade Capital Management
Virginia
-$3K

ZOM Hedge Fund Activity: Q3 2020 in Review

32 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in Zomedica Corp. (ZOM) for Q3 2020, worth a combined $3.59M — down 39% from $5.94M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new ZOM positions and 9 closed out — a net gain of 4 holders — while 10 added to existing stakes and 2 trimmed.

The largest buyer was Vanguard Group, adding an estimated $387K. The largest seller was BlackRock, exiting entirely with an estimated $221K sold.

  • 32 institutional investors held Zomedica Corp. (ZOM) as of Q3 2020, up from 28 in Q2 2020.
  • Funds reported $3.59M of Zomedica Corp. stock for Q3 2020, down 39% quarter-over-quarter.
  • 13 funds opened new Zomedica Corp. positions in Q3 2020 and 9 closed out, a net change of +4 holders.
  • The largest Zomedica Corp. buyer in Q3 2020 was Vanguard Group, an estimated $387K added.
  • The largest Zomedica Corp. seller in Q3 2020 was BlackRock, an estimated $221K sold.

Based on aggregated 13F filings for Q3 2020.